About Contact Us Careers
Sign In

Sepsis Diagnostics Market Size & Share, by Product (Assay Kits & Reagents, Blood Culture Media); Technology (Microbiology, Immunoassays, Flow Cytometry); Pathogen (Bacterial Sepsis, Fungal Sepsis); Testing Type (Laboratory Tests, POC Testing) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4869
  • Published Date: Apr 30, 2023
  • Report Format: PDF, PPT

Companies Dominating the Sepsis Diagnostics Landscape

top-features-companies
    • BioMérieux SA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Becton, Dickinson and Company
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche AG
    • Danaher Corporation (Beckman Coulter, Inc.)
    • Cepheid
    • Beckman Coulter, Inc.
    • Amara Health Analytics
    • Wolters Kluwer N.V.
    • Cerner Corp.
Browse Key Market Insights with Data Illustration:

In the News

  • Beckman Coulter announced the availability in the United States of its DxH 690T hematology analyzer, which is used as an early sepsis indicator. In addition, this announcement has contributed to the company's increased global presence and growth in revenues.
     
  • Prenosis Inc., a precision diagnostics company that uses artificial intelligence to better diagnose patients, renewed its existing agreement with Roche Diagnostics in order to accelerate the detection of sepsis.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4869
  • Published Date: Apr 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of hospital-acquired infections, the rising burden of sepsis in the world, and rising diagnostic developments are the major factors driving the market growth.

The market size of sepsis diagnostics is anticipated to attain a CAGR of 11.90% over the forecast period, i.e., 2023-2035.

High cost of diagnostics devices, and the shortage of skilled healthcare professionals are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are bioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter, Inc.), Cepheid, Beckman Coulter, Inc., Luminex Corp., Bruker Corp., Amara Health Analytics

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, technology, pathogen, testing type, and by region.

The blood culture media segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying